OK432 (Picibanil)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OK432 (Picibanil), covering 2021-10-28 to 2021-10-28. Get the full timeline:
Most recent: Clinical Trial Update: OK432 (Picibanil) in the Treatment of Lymphatic Malformations [Phase 2]